Drug
Aldesleukin
Aldesleukin: highest development phase Phase 2, developed by Iovance Biotherapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Iovance Biotherapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aldesleukin NCT03449108 | Phase 2 | Bone Sarcoma |
Latest
No recent events.
Follow Aldesleukin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.